News Releases Year: All News20182017201620152014 Items per page All News2550 Summary ToggleContraVir Pharmaceuticals Announces John Sullivan-Bolyai, M.D., MPH Steps Down as Chief Medical Officer Summary Toggle December 29, 2017 View News Release > Summary ToggleContraVir Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until December 21, 2017 Summary Toggle December 13, 2017 View News Release > Summary ToggleContraVir Pharmaceuticals to Make Three Presentations at HEP DART 2017 Summary Toggle November 27, 2017 View News Release > Summary ToggleContraVir Pharmaceuticals to Receive Non-Dilutive Funding through New Jersey Technology Business Tax Certificate Transfer (NOL) Program Summary Toggle November 6, 2017 View News Release > ContraVir Pharmaceuticals Provides Corporate Update and Reports 2017 Financial and Operational Results 491.6 KB Summary Toggle October 27, 2017 View News Release > Summary ToggleContraVir Pharmaceuticals Announces National Institutes of Health Funded Study on Antiviral Activity of CRV431 Summary Toggle October 24, 2017 View News Release > Summary ToggleContraVir Pharmaceuticals Initiated Dosing of Renally-Impaired Patients in First U.S. Trial with TXL™ Summary Toggle October 19, 2017 View News Release > Summary ToggleContraVir Pharmaceuticals Announces Research Collaboration Agreement with Li Ka Shing Institute of Virology Summary Toggle October 17, 2017 View News Release > Summary ToggleContraVir Pharmaceuticals to Present Three Posters at AASLD 2017 and Participate in the Search for HBV / HDV Cure Analyst Day Summary Toggle October 12, 2017 View News Release > Summary ToggleContraVir Pharmaceuticals to Present at The MicroCap Conference 2017 Summary Toggle October 3, 2017 View News Release > Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next Last page Last
ContraVir Pharmaceuticals Provides Corporate Update and Reports 2017 Financial and Operational Results 491.6 KB
